Get startedLog in
    Picture of NextCell Pharma AB logo

    NXTCL — NextCell Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: NextCell Pharma gets Approva; The Usage Of High-Dose Protrans In The Ongoing Clinical Trial

    Picture of NextCell Pharma AB logoNextCell Pharma AB
    29/06/2018 07:36
    June 29 (Reuters) - NextCell Pharma AB  NXTCL.TE :
    * THE DATA AND SAFETY MONITORING BOARD APPROVES THE USAGE OF HIGH-DOSE PROTRANS IN THE
ONGOING
CLINICAL TRIAL

Source text for Eikon:  ID:nWkr425KbW 
Further company coverage:  NXTCL.TE 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on NextCell Pharma AB

    See all news